IFN-γ promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b

[1]  W. V. van Weerden,et al.  NanoBiT System and Hydrofurimazine for Optimized Detection of Viral Infection in Mice—A Novel in Vivo Imaging Platform , 2020, International journal of molecular sciences.

[2]  Jung Min Lee,et al.  Current Knowledge and Future Perspectives on Mesenchymal Stem Cell-Derived Exosomes as a New Therapeutic Agent , 2020, International journal of molecular sciences.

[3]  S. Bishu,et al.  Th17 Cells in Inflammatory Bowel Disease: An Update for the Clinician. , 2020, Inflammatory bowel diseases.

[4]  Xiaowen He,et al.  Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism. , 2019, JCI insight.

[5]  S. Shi,et al.  Inhibition of Tet1- and Tet2-mediated DNA demethylation promotes immunomodulation of periodontal ligament stem cells , 2019, Cell Death & Disease.

[6]  S. Targan,et al.  Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. , 2019, The New England journal of medicine.

[7]  Y. Cong,et al.  MicroRNA-125a suppresses intestinal mucosal inflammation through targeting ETS-1 in patients with inflammatory bowel diseases. , 2019, Journal of autoimmunity.

[8]  Y. Wang,et al.  Immunosuppressive Effect of Exosomes from Mesenchymal Stromal Cells in Defined Medium on Experimental Colitis , 2019, International journal of stem cells.

[9]  Woo-Jin Song,et al.  Canine adipose tissue-derived mesenchymal stem cells pre-treated with TNF-alpha enhance immunomodulatory effects in inflammatory bowel disease in mice , 2019, Research in Veterinary Science.

[10]  F. Saldanha-Araújo,et al.  Mesenchymal stem cells immunomodulation: The road to IFN-γ licensing and the path ahead. , 2019, Cytokine & growth factor reviews.

[11]  J. Lötvall,et al.  Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders. , 2019, ACS nano.

[12]  W. Baldwin,et al.  IL-27 targets Foxp3+ Tregs to mediate antiinflammatory functions during experimental allergic airway inflammation. , 2019, JCI insight.

[13]  D. Qujeq,et al.  MiRNAs and inflammatory bowel disease: An interesting new story , 2018, Journal of cellular physiology.

[14]  P. Jedlicka,et al.  miR-106a deficiency attenuates inflammation in murine IBD models. , 2018, Mucosal Immunology.

[15]  P. Soon-Shiong,et al.  Pro inflammatory stimuli enhance the immunosuppressive functions of adipose mesenchymal stem cells-derived exosomes , 2018, Scientific Reports.

[16]  Lisheng Wang,et al.  Exosomes originating from MSCs stimulated with TGF‐β and IFN‐γ promote Treg differentiation , 2018, Journal of cellular physiology.

[17]  J. Sun,et al.  Deciduous autologous tooth stem cells regenerate dental pulp after implantation into injured teeth , 2018, Science Translational Medicine.

[18]  Y. Yi,et al.  Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis , 2018, Stem cell research & therapy.

[19]  P. Malfertheiner,et al.  Circulating and Fecal microRNAs as Biomarkers for Inflammatory Bowel Diseases. , 2018, Inflammatory bowel diseases.

[20]  Xiang Gao,et al.  Tet1 and Tet2 maintain mesenchymal stem cell homeostasis via demethylation of the P2rX7 promoter , 2018, Nature Communications.

[21]  Shao-Cong Sun,et al.  Epigenetic activation during T helper 17 cell differentiation is mediated by Tripartite motif containing 28 , 2018, Nature Communications.

[22]  T. Cai,et al.  The Fas/Fap-1/Cav-1 complex regulates IL-1RA secretion in mesenchymal stem cells to accelerate wound healing , 2018, Science Translational Medicine.

[23]  F. DiMeco,et al.  Constitutive and TNFα-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy , 2018, Science Translational Medicine.

[24]  A. Madi,et al.  SGK1 Governs the Reciprocal Development of Th17 and Regulatory T Cells , 2018, Cell reports.

[25]  J. Vykoukal,et al.  Inflammation‐Stimulated Mesenchymal Stromal Cell‐Derived Extracellular Vesicles Attenuate Inflammation , 2018, Stem cells.

[26]  B. Ryffel,et al.  microRNA cluster 106a~363 is involved in T helper 17 cell differentiation , 2017, Immunology.

[27]  Stefan Wirtz,et al.  Chemically induced mouse models of acute and chronic intestinal inflammation , 2017, Nature Protocols.

[28]  G. Vassalli,et al.  Exosomes: Therapy delivery tools and biomarkers of diseases , 2017, Pharmacology & therapeutics.

[29]  Minhu Chen,et al.  Upregulation of miR-665 promotes apoptosis and colitis in inflammatory bowel disease by repressing the endoplasmic reticulum stress components XBP1 and ORMDL3 , 2017, Cell Death & Disease.

[30]  R. Waddington,et al.  Variation in human dental pulp stem cell ageing profiles reflect contrasting proliferative and regenerative capabilities , 2017, BMC Cell Biology.

[31]  T. Mayadas,et al.  ICER is requisite for Th17 differentiation , 2016, Nature Communications.

[32]  S. Shi,et al.  MSC Transplantation Improves Osteopenia via Epigenetic Regulation of Notch Signaling in Lupus. , 2015, Cell metabolism.

[33]  Ha Won Kim,et al.  Exosomes Secreted from CXCR4 Overexpressing Mesenchymal Stem Cells Promote Cardioprotection via Akt Signaling Pathway following Myocardial Infarction , 2015, Stem cells international.

[34]  S. Kourembanas.  Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. , 2015, Annual review of physiology.

[35]  G. Kaplan,et al.  Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis. , 2015, Gastroenterology.

[36]  Lai Wei,et al.  Negative Regulation of Hif1a Expression and TH17 Differentiation by Hypoxia Regulated miR-210 , 2014, Nature Immunology.

[37]  P. Rutgeerts,et al.  Vedolizumab as induction and maintenance therapy for ulcerative colitis. , 2013, The New England journal of medicine.

[38]  J. Leonard,et al.  FedExosomes: Engineering Therapeutic Biological Nanoparticles that Truly Deliver , 2013, Pharmaceuticals.

[39]  S. Shi,et al.  A subset of IL-17+ mesenchymal stem cells possesses anti-Candida albicans effect , 2012, Cell Research.

[40]  Yang Yang,et al.  Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. , 2012, Stem cells and development.

[41]  A. Young,et al.  Fecal Lipocalin 2, a Sensitive and Broadly Dynamic Non-Invasive Biomarker for Intestinal Inflammation , 2012, PloS one.

[42]  T. Cai,et al.  Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. , 2012, Cell stem cell.

[43]  J. O’Shea,et al.  TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and constrains the plasticity of helper T cells , 2012, Nature Immunology.

[44]  D. Prockop,et al.  Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. , 2011, Blood.

[45]  D. Hommes,et al.  Pretreatment with Interferon‐γ Enhances the Therapeutic Activity of Mesenchymal Stromal Cells in Animal Models of Colitis , 2011, Stem cells.

[46]  Xiaodong Chen,et al.  Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair , 2010, Cell Research.

[47]  S. Shi,et al.  Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis , 2010, The Journal of Immunology.

[48]  S. Shi,et al.  Mesenchymal Stem Cells Derived from Human Gingiva Are Capable of Immunomodulatory Functions and Ameliorate Inflammation-Related Tissue Destruction in Experimental Colitis1 , 2009, The Journal of Immunology.

[49]  Lingyun Sun,et al.  Mesenchymal Stem Cell Transplantation Reverses Multiorgan Dysfunction in Systemic Lupus Erythematosus Mice and Humans , 2009, Stem cells.

[50]  P. Alex,et al.  Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS‐Induced Colitis , 2009, Inflammatory bowel diseases.

[51]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[52]  S. Setty,et al.  IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease , 2008, European journal of immunology.

[53]  A. Nauta,et al.  Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.

[54]  M. Yacoub,et al.  Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. , 2006, Tissue engineering.

[55]  M. Pittenger,et al.  Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.

[56]  Ulrich Göbel,et al.  bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 20, 2013. For personal use , 2004 .

[57]  C. Melief,et al.  B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.

[58]  Cheuk-Kwan Sun,et al.  Synergistic effect of combined melatonin and adipose-derived mesenchymal stem cell (ADMSC)-derived exosomes on amelioration of dextran sulfate sodium (DSS)-induced acute colitis. , 2019, American journal of translational research.

[59]  M. Nasr-Esfahani,et al.  miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing–remitting multiple sclerosis , 2015, Immunogenetics.